These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2036826)

  • 1. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
    Albain KS; Crowley JJ; Livingston RB
    Chest; 1991 Jun; 99(6):1425-32. PubMed ID: 2036826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
    Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
    J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1991 Sep; 9(9):1618-26. PubMed ID: 1651993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
    Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
    J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
    Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
    Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
    Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
    Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
    J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB; Griffin BR; Higano CS; Laramore GE; Rivkin SE; Goldberg RS; Schulman SF
    J Clin Oncol; 1987 Nov; 5(11):1716-24. PubMed ID: 2824705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and prognostic staging system for small cell lung cancer.
    Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
    Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.
    Albain KS; Crowley JJ; Turrisi AT; Gandara DR; Farrar WB; Clark JI; Beasley KR; Livingston RB
    J Clin Oncol; 2002 Aug; 20(16):3454-60. PubMed ID: 12177106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multimodality therapy concept in stage I-IIIA small cell bronchial carcinoma. Case follow-up over 15 years].
    Allica E; Serke M; Loddenkemper R; Kaiser D
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():596-600. PubMed ID: 11824323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer survival: 3 years as a minimum for predicting a favorable outcome.
    Lewiński T; Zuławski M
    Lung Cancer; 2003 May; 40(2):203-13. PubMed ID: 12711123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
    Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study.
    Livingston RB; Stephens RL; Bonnet JD; Grozea PN; Lehane DE
    Am J Med; 1984 Sep; 77(3):415-7. PubMed ID: 6089560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
    Finkelstein DM; Ettinger DS; Ruckdeschel JC
    J Clin Oncol; 1986 May; 4(5):702-9. PubMed ID: 3701389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
    J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.